Recombinate Package Insert

Instructions For Use ADVATE [Antihemophilic Factor ...
Without touching the inside of the package. Do not remove the BAXJECT II device from the package. 5. Turn the package with the BAXJECT II device upside down and place it over the top of the diluent vial. Fully insert the clear plastic spike of the device into the center of the diluent vial’s stopper by pushing straight down. Grip the package ... View Full Source

SPECIALTY GUIDELINE MANAGEMENT
Reference number(s) 1937-A 1938-A 1946-A 1939-A 1945-A SPECIALTY GUIDELINE MANAGEMENT . FACTOR VIII CONCENTRATES . POLICY . I. INDICATIONS . The indications below including FDA-approved indications and compendial uses are considered a covered ... View Document

Antihemophilic Factor (Human) Monoclate-P Factor VIII:C ...
Monoclate-P® is a highly purifi ed preparation of Factor VIII:C. When stored as directed, it will When stored as directed, it will maintain its labeled potency for the period indicated on the container and package labels. 6,7 ... Get Content Here

UConn Health Department Of Pharmacy Procoagulant (Factor ...
Storage/Stability. Humate-P: FEIBA NH FEIBA . BeneFix Humate P given over 3-20 min (Max 4mL/min) max rate of 2 units/kg/min. Benefix given at a rate of ... Access Content

SPECIALTY GUIDELINE MANAGEMENT - Providers.bcidaho.com
Recombinate antihemophilic factor [recombinant] Hemophilia A Acquired Hemophilia A Xyntha antihemophilic factor 1. Advate [package insert]. Westlake Village, CA: Baxter Healthcare Corporation; May 2015. 2. Helixate FS [package insert]. Whippany, NJ: Bayer HealthCare LLC; May 2016. ... Content Retrieval

SPECIALTY GUIDELINE MANAGEMENT - Provider.carefirst.com
Recombinant Factor VIII Concentrates Advate . antihemophilic factor [recombinant] Hemophilia A . Recombinate or Xyntha may be granted for treatment of hemophilia A when either of the 1. Advate [package insert]. Westlake Village, CA: Baxter Healthcare Corporation; November 2016. 2 ... Fetch Content

Marquette General Health System Pharmacy And Therapeutics ...
Marquette General Health System Pharmacy and Therapeutics Committee (Recombinate ) (Provided) 5 micron filter needle Not required Use one filter needle per vial. 1, 2 Package insert 3. Trissel, 10th edition 4. Lacy CF, Armstrong LL, Goldman MP, Lance LL. ... Get Content Here

PHARMACY POLICY STATEMENT - Caresource.com
Package insert for dosing, administration and safety guidelines. If member meets all the requirements listed above, the medication will be approved for 6 months. For ... Read Content

HIGHLIGHTS OF PRESCRIBING INFORMATION These Highlights Do Not ...
FULL PRESCRIBING INFORMATION Helixate® FS Antihemophilic Factor (Recombinant) Formulated with Sucrose 1TIONS AND USAGE INDICA Helixate® FS is a recombinant antihemophilic factor indicated for: • On-demand treatment and control of bleeding episodes in adults and children with ... Fetch Document

PHARMACY POLICY STATEMENT - CareSource
PHARMACY POLICY STATEMENT Original Effective Date • Recombinate [Antihemophilic Factor (Recombinant)] • Refer to the product package insert for dosing, administration and safety guidelines. 3. Dosage and Quantity Limits (listed if applicable) ... Access Doc

1 INDICATIONS AND USAGE - Bayer HealthCare
1 INDICATIONS AND USAGE Kogenate® FS is a recombinant antihemophilic factor indicated for: On-demand treatment and control of bleeding episodes in adults and children with hemophilia A. Perioperative management of bleeding in adults and children with hemophilia A. ... Read More

Guidelines For The Administration Of Cryoprecipitate
GUIDELINES FOR THE ADMINISTRATION OF CRYOPRECIPITATE INTRODUCTION Cryoprecipitate, or “cryo”, whose official U.S. Food and Drug Administration (FDA) name is Cryoprecipitated Antihemophilic Factor, is the cold-insoluble portion of fresh frozen plasma (FFP) that precipitates when FFP is thawed at refrigerator temperatures (1-6 C). Considered a ... Return Doc

Thrombosis Factor IX Complex Profilnine Surgery, Post Surgery ...
1 Factor IX Complex Profilnine® surgery, post surgery, with known liver disease, and with signs of fibrinolysis, thrombosis, or DESCRIPTION Profilnine®, Factor IX Complex, is a solvent/detergent treated, nanofiltered, sterile, lyophilized concentrate of coagulation factors IX, II, X, and low levels of factor VII. ... Fetch Here

US Hemophilia Factor Brands By Company And Type
Recombinate : Rixubis . Hemofil M . Proplex-T : Bebulin VH . FEIBA VH : Italicized brand names indicate extended half-life products. Because there is no consensus on what constitutes an extendedhalf-life product, check the package insert (PI) carefully. ... Get Doc

SPECIALTY GUIDELINE MANAGEMENT - Harvardpilgrim.org
Recombinate antihemophilic factor [recombinant] Hemophilia A Acquired Hemophilia A Xyntha antihemophilic factor 1. Advate [package insert]. Westlake Village, CA: Baxter Healthcare Corporation; November 2016. 2. Helixate FS [package insert]. Whippany, NJ: Bayer HealthCare LLC; May 2016. ... Read Full Source

Step Therapy Recombinate 102517PT - Uhcprovider.com
Recombinate® [package insert]. Westlake Village CA: Baxalta US Inc., November 2015. 2. MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders. Med Bulletin #249, May 19, 2017. 3. ... Retrieve Here

Pharmacy Policy Bulletin - Ibx.com
Pharmacy Policy Bulletin Title: Hemophilia Agents Policy #: Rx.01.149 Application of pharmacy policy is determined by benefits and contracts. Benefits may vary based on product line, group, or ... Fetch Doc

Recombinant Factor VIII (Page 1 Of 2) - BDI Pharma
Recombinant Factor VIII (Page 1) Product Specifics ADVATE RECOMBINATE. The cell culture, pegylation, purification process and formulation used in • Store AFSTYLA in the original package to protect the AFSTYLA vials from light. ... Visit Document